Kimberly Stegmaier, MD, Professor of Pediatrics at Harvard Medical School and the Ted Williams Investigator at Dana-Farber Cancer Institute, has advanced the application of genomics to drug and protein target discovery for pediatric malignancies. She is the Vice Chair for Pediatric Oncology Research and Co-director of the Pediatric Hematologic Malignancies Program at Dana-Farber Cancer Institute and Boston Children’s Hospital and an Institute Member of the Broad Institute.
Dr. Stegmaier is on the Board of Directors of the American Association for Cancer Research (AACR) and is the former Chair of the St. Jude Children’s Research Hospital Scientific Advisory Board and the AACR Pediatric Cancer Working Group.
Dr. Stegmaier is the recipient of numerous awards, such as a Stand Up to Cancer (SU2C) Innovative Research Grant, an A. Clifford Barger Excellence in Mentoring Award from Harvard Medical School, the E. Mead Johnson Award for Research in Pediatrics, and an NCI Outstanding Investigator Award. Dr. Stegmaier received her undergraduate degree from Duke University where she graduated valedictorian, medical degree from Harvard Medical School, and trained in Pediatrics and Pediatric Hematology/Oncology at Boston Children’s Hospital and Dana-Farber Cancer Institute.
